← FDA Drug Approvals (Drugs@FDA)
LUXZYLA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANI PHARMS · Approved 2019-05-07
Drug application
- FDA Application #
ANDA209921- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LUXZYLA
- Generic name
- Penicillamine
- Active ingredients
- PENICILLAMINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ANI PHARMS
- First approval
- 2019-05-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown